Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOLAB A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3%   Bankruptcy risk   1.4% 1.0% 1.0% 1.0% 1.0% 0.9% 8.7% 8.7%   Credit score (0-100)   80 87 86 86 88 88 28 28   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   44.3 417.3 457.7 481.2 561.3 776.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   7,353 8,647 9,147 9,408 8,555 9,800 0.0 0.0   EBITDA   783 1,867 2,170 2,566 1,769 2,785 0.0 0.0   EBIT   754 1,838 2,146 2,538 1,752 2,774 0.0 0.0   Pre-tax profit (PTP)   829.5 1,832.4 2,397.6 2,534.2 1,793.0 2,875.9 0.0 0.0   Net earnings   643.4 1,426.3 1,868.4 1,974.6 1,398.0 2,241.7 0.0 0.0   Pre-tax profit without non-rec. items   830 1,832 2,398 2,534 1,793 2,876 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   89.4 60.2 36.7 72.0 54.0 44.1 0.0 0.0   Shareholders equity total   3,038 3,964 4,333 4,507 5,005 5,847 5,347 5,347   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,884 10,628 10,328 8,022 8,418 11,183 5,347 5,347   Net Debt   -286 -3,601 -2,682 -530 -2,775 -2,335 -5,347 -5,347     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   7,353 8,647 9,147 9,408 8,555 9,800 0.0 0.0   Gross profit growth   -11.6% 17.6% 5.8% 2.9% -9.1% 14.6% -100.0% 0.0%   Employees   0 10 10 10 10 10 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,884 10,628 10,328 8,022 8,418 11,183 5,347 5,347   Balance sheet change%   -18.1% 54.4% -2.8% -22.3% 4.9% 32.9% -52.2% 0.0%   Added value   782.7 1,866.9 2,170.0 2,566.1 1,779.7 2,785.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -58 -58 -47 8 -35 -21 -44 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.2% 21.3% 23.5% 27.0% 20.5% 28.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.0% 21.4% 23.1% 27.8% 22.0% 29.4% 0.0% 0.0%   ROI %   25.3% 49.7% 51.3% 53.9% 38.0% 53.2% 0.0% 0.0%   ROE %   19.4% 40.7% 45.0% 44.7% 29.4% 41.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   44.1% 37.3% 42.0% 56.2% 59.5% 52.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -36.6% -192.9% -123.6% -20.6% -156.9% -83.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.9 1.2 1.4 1.4 1.4 1.5 0.0 0.0   Current Ratio   1.8 1.8 2.1 2.6 2.7 2.3 0.0 0.0   Cash and cash equivalent   286.1 3,601.4 2,682.3 529.7 2,775.0 2,335.2 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,067.9 4,746.9 5,358.3 4,915.0 5,266.0 6,315.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 187 217 257 178 279 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 187 217 257 177 279 0 0   EBIT / employee   0 184 215 254 175 277 0 0   Net earnings / employee   0 143 187 197 140 224 0 0